Lentivirus gene engineering protocols / edited by Maurizio Federico. — 2nd ed. — New York. : Humana, c2010. – (58.17/M592/v.614) |
Contents
Contents
Contributors
PART I OVERVIEW
1 Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions
PART II ADVANCES IN LENTIVIRAL VECTOR TECHNOLOGY
2 New Protocol for Lentiviral Vector Mass Production
3 Flexibility in Cell Targeting by Pseudotyping lentiviral Vectors
4 Doxycycline Regulated lentiviral Vectors
5 Strategies to Insulate Lentiviral Vector-Expressed Transgenes
6 Integrase Detective, Nonintegrating Lentiviral Vectors
7 Lentivirus-Based Virus-Like Particles as a New Protein Delivery Too
PART III NEW LENTIVIRAL VECTOR APPLICATIONS
8 Lentiviral Vector-Mediated Transgenesis in Human Embryonic Stem Cells 127
9 Lentiviral Vector Transduction of Fetal Mesenchymal Stem Cells
l0 Manipulating the Cell Differentiation Through Lentiviral Vectors
11 Lentiviral Vector Transduction of Dendritic Cells for Novel Vaccine Strategies
PART IV THE SHORT KNA TECHNOLOGIES APPLIED BY LENTIVIRAL VECTORS
12 Lentiviral Vector-Mediated Expression of pre-miRNAs and AntagomiRs
13 Tile RNA Silencing Technology Applied by Lentiviral Vectors in Oncology
14 Lentiviral Vector Engineering for Anti-HIV RNAi Gene Therapy
15 Lentivirus-Expressed siRNA Vectors Against Alzheimer Disease 215
Index